Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
inVentiv
CRO
Cel-Sci wins 4.5-year-long arbitration case against CRO
Cel-Sci won a yearslong arbitration battle with inVentiv, now known as Syneos Health, over breach of contract and missed phase 3 enrollment promises.
Conor Hale
Jul 10, 2018 4:18pm
INC Research/inVentiv Health rebrands as Syneos Health
Jan 8, 2018 8:27am
INC boosts presence in Japan, Asia with new move
Jun 29, 2017 3:44am
Chutes & Ladders—Alexion overhauls its C-suite
May 25, 2017 2:42pm
Cel-Sci creates new problems for Multikine at the FDA
May 24, 2017 8:50am
Chutes & Ladders—Scott Gottlieb confirmed as FDA commissioner
May 11, 2017 7:02pm
